####################
# Output from PRIME (v1.0)
# Alleles: HLA-B44:02
# Affinity predictions: MixMHCpred (/Users/annieborch/Documents/programs/MixMHCpred-master/MixMHCpred)
# PRIME is freely available for academic users.
# Private companies should contact eauffarth@licr.org at the Ludwig Institute for Cancer Research Ltd for commercial licenses.
#
# To cite PRIME, please refer to:
# Schmidt et al. Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and immunoediting in human cancer, BioRxiv (2020).
#
####################
Peptide	%Rank_bestAllele	Score_bestAllele	%RankBinding_bestAllele	BestAllele	%Rank_HLA-B44:02	Score_HLA-B44:02	%RankBinding_HLA-B44:02
EEQEEEGGSWG	4.00	0.162346	0.60	HLA-B44:02	4.00	0.162346	0.60
NEEDSEDLF	0.60	0.173115	0.20	HLA-B44:02	0.60	0.173115	0.20
SNEEDSEDLF	30.00	0.151719	3.00	HLA-B44:02	30.00	0.151719	3.00
LKNNSGWRW	2.00	0.168960	2.00	HLA-B44:02	2.00	0.168960	2.00
GEFQCSRKA	7.00	0.158731	0.50	HLA-B44:02	7.00	0.158731	0.50
EEFKGQYFH	0.70	0.173013	0.50	HLA-B44:02	0.70	0.173013	0.50
HRGEAEFARIM	100.00	0.000000	16.00	HLA-B44:02	100.00	0.000000	16.00
DEEQEEEGGSW	8.00	0.157924	0.20	HLA-B44:02	8.00	0.157924	0.20
TEEDSKECL	0.90	0.171150	0.10	HLA-B44:02	0.90	0.171150	0.10
EQEEEGGSW	20.00	0.152862	0.60	HLA-B44:02	20.00	0.152862	0.60
SDNSPSQLGF	20.00	0.155069	2.00	HLA-B44:02	20.00	0.155069	2.00
GDDAPWAVF	100.00	0.000000	13.00	HLA-B44:02	100.00	0.000000	13.00
